Table 3.
Antimicrobial activity against S. aureus and E. coli of the PCL-based films.
| Formulation | S. aureus | E. coli | ||
|---|---|---|---|---|
| Bacterial Counts log CFU/mL |
Surface Reduction R |
Bacterial Counts log CFU/mL |
Surface Reduction R |
|
| Control | 6.10 ± 0.09 | - | 7.09 ± 0.12 | - |
| PCL | 5.77 ± 0.15 | 0.33 | 6.89 ± 0.09 | 0.20 |
| PCL-SE5 | no viable counts | biocidal effect | 6.36 ± 0.13 | 0.73 |
| PCL-SE10 | no viable counts | biocidal effect | 6.18 ± 0.16 | 0.91 |
| PCL-SE20 | no viable counts | biocidal effect | 2.40 ± 0.52 | 4.69 |
CFU—Colony Forming Units; R—Surface Reduction.